Nita Radhakrishnan: Discussing Risks, Benefits, and Uncertainties in Hemoglobinopathy Care
Nita Radhakrishnan, Additional Professor and HOD of Pediatric Hematology-Oncology at Post Graduate Institute of Child Health, shared TIF‘s post on LinkedIn:
“Shared Decision Making in Hemoglobinopathy care
– Looking forward to discussing the risks, benefits, uncertainties, and vulnerabilities of treatment options in every day practice –
30 June 2026 Thalassaemia International Federation (TIF) Webinar Series”
Thalassaemia International Federation (TIF) shared a post on LinkedIn:
“On 30 June 2026, the TIF Webinar Series returns with a conversation that places partnership at the centre of haemoglobinopathy care:
‘Shared Decisions, Better Outcomes: Collaborative Care in Thalassaemia and SCD‘
From everyday care to newer therapeutic options, people living with Thalassaemia and Sickle Cell Disease deserve information they can understand, space to ask questions, and a genuine role in decisions that affect their lives.
Moderated by Mr. Frank Somma, Advocate and Community Leader in Haemoglobin Disorders, this 90-minute webinar brings together distinct yet equally essential voices:
- Dr. Ioanna Ampati — Principal Psychologist and Lead for Haemoglobin Disorders Psychology Service, NHS London, UK
- Ms. Shakeela Bashir Ahmed — Administrative Officer, Emirates Thalassaemia Society, UAE, and an adult living with beta thalassaemia major
- Dr. Nita Radhakrishnan — Additional Professor and Head of the Department of Pediatric Hematology-Oncology, India
- Ms. Nadia Nihat — Mother, caregiver, and patient advocate, UK
In a candid, practical exchange, the panel will discuss what it takes to turn consultation into genuine collaboration.
Join us on 30 June 2026, at 19:00 EEST (Cyprus time) / 12:00 New York time, for this important discussion on Zoom.
The TIF Webinar Series 2026 on effective health communication is supported by Bristol Myers Squibb (BMS), Agios Pharmaceuticals, and Avanzanite Bioscience.”

Other posts featuring Nita Radhakrishnan on Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery